NovoCure Ltd NVCR 50.55
Health Care · NASDAQ · Data as of 2026-10-29
NovoCure Ltd (NVCR) has delivered +21.5% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #885 of 1968 stocks overall and #94 of 260 in the Health Care sector by Steady Score.
Industry
Surgical & Medical Instruments
Steady Score
50.55
Overall Rank
#885 / 1968
Sector Rank
#94 / 260
Revenue CAGR
+21.5%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio